Fidelity Select Pharmaceuticals Portfolio
FPHAX
NASDAQ
| Weiss Ratings | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Reward Grade | B | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Company Info | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Fidelity Investments | |||
| Manager/Tenure (Years) | Karim Suwwan de Felipe (8) | |||
| Website | http://www.institutional.fidelity.com | |||
| Fund Information | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Fidelity Select Pharmaceuticals Portfolio | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Jun 18, 2001 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 0.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.37% | |||
| Dividend | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.79% | |||
| Asset Allocation | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.31% | |||
| Stock | 98.07% | |||
| U.S. Stock | 58.56% | |||
| Non-U.S. Stock | 39.51% | |||
| Bond | 0.10% | |||
| U.S. Bond | 0.10% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 1.52% | |||
| Price History | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.74% | |||
| 30-Day Total Return | -3.21% | |||
| 60-Day Total Return | -0.98% | |||
| 90-Day Total Return | -1.71% | |||
| Year to Date Total Return | -1.37% | |||
| 1-Year Total Return | -13.11% | |||
| 2-Year Total Return | 15.67% | |||
| 3-Year Total Return | 24.54% | |||
| 5-Year Total Return | 43.31% | |||
| Price | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $24.07 | |||
| 1-Month Low NAV | $23.79 | |||
| 1-Month High NAV | $26.09 | |||
| 52-Week Low NAV | $22.01 | |||
| 52-Week Low NAV (Date) | Apr 11, 2025 | |||
| 52-Week High NAV | $31.58 | |||
| 52-Week High Price (Date) | Aug 30, 2024 | |||
| Beta / Standard Deviation | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.61 | |||
| Standard Deviation | 16.26 | |||
| Balance Sheet | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.04B | |||
| Operating Ratios | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.67% | |||
| Turnover Ratio | 51.00% | |||
| Performance | FPHAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 1.25% | |||
| Last Bear Market Total Return | -2.37% | |||